One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
When algorithms speak first: The public health risk of consumer AI in ALS diagnosis
Intra-arterial thrombolytics after endovascular thrombectomy for acute ischemic stroke: A network meta-analysis of RCTs
Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study
Early use of low dose rituximab in anti acetylcholine receptor generalized myasthenia gravis in South Wales – A retrospective study
Long-term treatment with Eptinezumab in special treatment situations: Real world data
Trends in antiseizure medication use among women of childbearing age with epilepsy
Association of hypoxic burden with brain atrophy in Alzheimer's disease
Riboflavin therapy in complex I deficiency: Two new cases of leukoencephalopathy and a systematic literature review
Involuntary inspiratory sigh in multiple system atrophy: A clinical and cerebral blood flow study
Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability–weighted analysis
Rituximab in AChR and MusK Myasthenia Gravis: long-term follow-up with different therapeutic protocols
Association between glucagon-like peptide-1 receptor agonist use and ischemic stroke severity
The International Alliance on Brain Health (IABH): Bridging global efforts toward integrated brain and mental health plans and the promotion of local implementations
Pathology of general proprioception in a canine disease model of amyotrophic lateral sclerosis
Lower atrial fibrillation detection in cryptogenic stroke patients with patent foramen ovale: Evidence from insertable cardiac monitoring
Early antihypertensive therapy in acute ischemic stroke: A Meta-analysis of randomized controlled trials
Demonstrating clinical and radiological variability of adult-onset Alexander disease in three siblings
Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis
Letter to the editor: France-Ratcliffe M, et al. ‘Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS’ [Journal of the Neurological Sciences 488 (2026) 126007]
Mental health comorbidity and multiple sclerosis outcomes: Clarifying progression through longitudinal, imaging, and equity-focused markers
Comment on “the neuropsychiatric features of long COVID in older adults and the potential association with neuroinflammation: Preliminary observations in a small cohort”
Response to Comment on “Agreement between the simplified Edinburgh CT criteria and the Boston MRI criteria v2.0 for cerebral amyloid angiopathy diagnosis in lobar intracerebral haemorrhage from a population-based perspective. Dijon Stroke Registry”
Comment on “Agreement between the simplified Edinburgh CT criteria and the Boston MRI criteria v2.0 for cerebral amyloid angiopathy diagnosis in lobar intracerebral haemorrhage from a population-based perspective. Dijon stroke registry”
Reply to “Comments on sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis”
Comments on “Sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis”
Neuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform
Is hypocapnia a marker of injury severity rather than a therapeutic target after acute ischemic stroke?
Response to letter regarding article “Suspected autoimmune cerebellar ataxia: Predictors of immunotherapy response and diagnosis reclassification to neurodegenerative disease”
Comment on “Suspected autoimmune cerebellar ataxia: Predictors of immunotherapy response and diagnosis reclassification to neurodegenerative disease”
A response to “Is hypocapnia a marker of injury severity rather than a therapeutic target after acute ischemic stroke?”
Mortality in facioscapulohumeral muscular dystrophy requires exclusion of mitochondrial and other neuromuscular differentials
Interpreting plasma p-tau217 discordance in real-world memory clinics
Comment on “Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission”
Comment on “Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission”
Acute akinetic collapse in Parkinson's disease: The need for a non-parkinsonian comparator and clearer Nosological boundaries
Comment on “Global, regional and national burden of Parkinson's disease, 1990–2021: Update from the GBD 2021 study”
